Meeting
2021 Genitourinary Cancers Symposium
Time trends of drug specific adverse events among patients on androgen receptor antagonists: Implications for remote monitoring.
Authors
Lauren Fleshner
University Health Network, Toronto, ON, Canada
Lauren Fleshner , Sophie O'Halloran , Katherine Lajkosz , Jacob Wise , Miran Kenk , Susan Nguyen , Neil Eric Fleshner
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session: Prostate Cancer - Advanced Disease
Track
Prostate Cancer - Advanced
Sub Track
Impact of COVID-19
Citation
J Clin Oncol 39, 2021 (suppl 6; abstr 40)
DOI
10.1200/JCO.2021.39.6_suppl.40
Abstract #
40
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Genitourinary Cancers Symposium
Statin type and survival of patients with metastatic castrate-resistant prostate cancer receiving abiraterone and enzalutamide: A nationwide retrospective cohort study.
First Author: Harrison Yoon
Poster
2021 ASCO Annual Meeting
Survival of veterans treated with enzalutamide and abiraterone in advanced prostate cancer.
First Author: Martin W. Schoen
Poster
2020 Genitourinary Cancers Symposium
Financial hardship among Medicare beneficiaries prescribed oral targeted therapies for advanced prostate cancer.
First Author: Megan Veresh Caram
Poster
2017 ASCO Quality Care Symposium
Early national dissemination of abiraterone and enzalutamide for advanced prostate cancer in Medicare Part D.
First Author: Megan Veresh Caram